Intensity Therapeutics Recognized with GHP Magazine’s 2026 Healthcare & Pharmaceutical Award
May 14, 2026
Technology
-
-
INmune Bio Receives FDA Fast Track Designation for XPro1595 in Early Alzheimer’s Disease
May 14, 2026
-
XORTX Announces US$5 Million Public Offering
May 14, 2026
-
Tiziana Reports Reduced Brain Inflammation in Multiple System Atrophy Patients Treated with Intranasal Foralumab
May 14, 2026
-
POET Technologies and Lumilens Advance Wafer-Level Photonic Integration for Next-Generation AI Optical Networks
May 14, 2026
-
Biodexa issues letter to Shareholders
May 14, 2026
-
BrainChip Expands AI Ecosystem with Strategic Software Partners
May 14, 2026
-
The Radoff-JEC Group Submits its Third Non-Binding Proposal to Acquire Seer, Inc.
May 14, 2026
-
ISG to Study Providers of AI-driven ADM Services
May 14, 2026
-
Veritone Launches Job Acceleration, Giving Hiring Teams More Control Over Urgent Hiring Needs
May 14, 2026
-
ImagineAR Provides Corporate Update and Reports Progress on Patent Portfolio
May 13, 2026
-
PolyPid Provides Corporate Update and Reports First Quarter 2026 Financial Results
May 13, 2026
-
Palatin Reports Fiscal Third Quarter 2026 Financial Results and Provides Business Update
May 13, 2026
-
Global Mofy Strategically Participates in New Financing Round of Kimi AI’s Developer Moonshot AI, Advancing Its Global Generative AI Strategy
May 13, 2026
-
VNET Announces New Strategic Investors
May 13, 2026
-
Lantern Pharma Inc. Announces up to $9.25 Million Registered Direct Offering with Existing Holders and a Single Institutional Investor
May 13, 2026